We Speak Patient
We are a patient engagement consultancy committed to making the R&D process better.
Much better.
We have deep expertise in understanding how patient perspectives can bring value into R&D, and how to optimize outcomes for our clients and the patients they serve within this highly regulated and complex industry.
01
Patient Engagement Plan (PEP)
The value of an engaged patient is enormous to any R&D process. Legacy’s PEP platform creates a map for how, when, and why your team wants to engage with patients and care partners throughout an asset’s lifecycle.


02
Trial-Ready Communities (TRC)
Our TRC platform ensures faster recruitment, better retention, and more medicines of value come to patients sooner. It is what patients want, what companies need, and what Legacy is all about.
Tailor-made solutions for our clients
What is it? A systematic and thorough process completed in several weeks that provides the basis for a customized approach to clients’ needs shared in a final report with recommendations and collaborative conversation.
What problem does it address? Many biopharma and med-tech companies see other companies moving forward with patient engagement activities, but they do not know how to get started. Or, companies may be conducting some activities sporadically, and they want to understand how to do more. In both cases, companies are eager to learn from the learn from subject matter experts in this niche and rapidly evolving field.
What is our approach? Optimizing the benefits of patient perspectives in research and development has many potential paths that need to be prioritized and tailored to the strategic priorities, challenges, and culture of an organization. We believe customized solutions must build on the knowledge and expertise of internal stakeholders at a project or program team level, R&D, and corporate. Our methodology provides for gathering this information, analyzing these factors, and combining this analysis with our deep experience in the Patient Engagement landscape to produce a final assessment and proposed next steps.
What results do we see? Increased understanding of the current state and desired future state of Patient Engagement across the organization for leaders at all levels and critical insights as to key prioritized areas across the organization where Patient Engagement may specifically help address challenges or further enhance efforts. The result is tailor-made approaches that help companies navigate better outcomes and value for those they serve faster.
What is it? An insight gathering opportunity to aid in the design of Decentralized Clinical Trials (DCTs) that provides for deeper understanding of the specific needs of the intended clinical trial population.
What problem does it address? Many elements of DCTs better meet the needs of patients however it is far from a “one size fits all” solution. For any given condition, clinical trial, geography or condition, there are a range of factors to consider in the design of a DCT to help ensure patient will want to participate and stay in trials.
What is our approach? A patient advisory board of six-ten individuals living with a given condition meet with an internal team designing a DCT. Trust, transparency, and collaboration are established as the working team discuss the elements of the DCT that are being considered and the benefits or challenges they pose. External vendors technology, central labs, nursing care organizations, can also join and brainstorm opportunities and potential solutions that focus on the needs of patients at the creation level rather than feedback after a trial is design or a remote monitoring device is even selected.
What results do we see? Internal stakeholders and vendor partners are extremely motivated and keenly interested in meeting the needs of actual patients who bring important insights into the discussion. The sense of purpose and urgency is palpable, and money is not spent on technology or solutions that patients are not able to use but rather is focused on what will meet the needs of the trial and the participant. Flexibility is incorporated where possible to meet the needs of a particular trial population including typically underrepresented subpopulations.
What is it? A program developed in partnership with a biopharmaceutical or med-tech company to increase awareness or education around a given condition is often intended for a hard-to-reach community and one where a “hero” from that community can help attract and engage individuals to learn.
What problem does it address? Underrepresented communities are often left behind, facing worse outcomes when receiving care for health or opportunities to participate in some of the most advanced medicine offered in clinical trials. In addition, many people are turning to social health online for answers to their health concerns and are provided support, resources, and information that they might find valuable to inform their health care decision through traditional routes such as their health care providers.
What is our approach? We create programs that meet our clients’ needs and engage communities around a “hero” to bring increased awareness, education, resources, and inspire hope. Activities can be virtual or in-person and are designed to reach people where they are, to empower people in their health care journey, and to help them feel less alone. At the same time, these communities may gain from more specific outputs of an engagement that benefits both the community and our clients.
What results do we see? The results of community awareness and engagement programs are the shared benefit we can deliver for our clients and the gratefulness our clients receive from community members that helps build trust, reputation, and better outcomes for both companies and the patients they serve.
Why Forward-Thinking Biopharma and Med-tech Companies Work With Us
We speak industry, and we speak patient. Our leadership team has decades of experience building programs that lead to better patient outcomes, lower costs, and more profound program learnings. We are already up to speed on what works well and how it affects your R&D process.
Everyone from Legacy demonstrated expertise and passion regarding the topics discussed. Within only a few moments, I was engaged and eager to learn. The material discussed will be extremely valuable to me in my role.
“You demonstrated incredible, authentic passion on the patient journey that was inspirational. Your presentation received overwhelmingly high remarks and our team was moved by just how personal you made it for all of us.”
This is an amazingly successful project and clearly, one that’s very much needed and appreciated by virtually every one of the participants. They are all profoundly grateful that someone cares this much about them.
“My experience at my company is better because I had the chance to work with you. Your brilliance and high touch are assets that are hard to replicate.

Thanks Rolf. You were amazing as always and right on point. I love how the patient is starting to take center stage!!



















“Rolf is an extraordinary speaker who understands the value of communicating an organization’s mission and vision. He speaks with compassion, intellect and sincerity.”



















“You demonstrated incredible, authentic passion on the patient journey that was inspirational. Your presentation received overwhelmingly high remarks and our team was moved by just how personal you made it for all of us.”



















“Best speech I have ever heard. Ever. Completely authentic, heart-felt, funny and inspirational. Honestly, the speech hit it out of the park. We can only hope the medical school graduates took this message of compassion, teamwork, and humility to heart, and carry it forward.”



















“I found your message to be very inspirational both from a professional and personal perspective, and I was very impressed with your knowledge of our industry. Not all speakers do their homework!”



















Everyone from Legacy demonstrated expertise and passion regarding the topics discussed. Within only a few moments, I was engaged and eager to learn. The material discussed will be extremely valuable to me in my role.



















Thank you for sharing your story today in the Townhall; it was not only exceptionally moving, it gave me some much needed perspective.



















“Thank you all for your dedicated work. Trust me, everyone of you are really appreciated. Your study has and will continue to change people’s lives. To you all”






































“I admire your humanity, passion, and management style a lot and cannot thank you enough for all the support and the guidance you have shared with me.”



















"I wanted to thank you for all you and the team have done for [our] programs. We’ve learned so much from these patient interactions.”



















“My experience at my company is better because I had the chance to work with you. Your brilliance and high touch are assets that are hard to replicate. You are a great ally and champion of DE&I. At the same time, you set an example for us, about life, career, and how to channel our commitment.”



















“I thoroughly enjoyed our interactions, and your perspective was so important in defining our patient engagement activities. Thank you so very much for all your help and guidance.



















“This field is better because you are in it! I wish you all the best and thank you for both your contributions to our work and the examples you set.”



















“As a young person entering this field, it has been an inspiration to see how you elevate the patient perspective in your work. It is always a pleasure to work with you.”



















“Your vision, energy and commitment to patient engagement have made a major contribution to the drug development enterprise.



















“You have achieved amazing things in such a short space of time. No other pharma company has embedded patient engagement so fully, so quickly, and that is very much the result of your leadership and the work of your fantastic team. It has been an absolute pleasure working with this you this past year.”



















“Your passion for patient engagement, expertise and leadership is a treasure that I know you will continue to use to further advance this important work.”